What Genfar does

Genfar is a Latin American generic pharmaceutical manufacturer founded in 1967 in Bogotá, Colombia, that produces and commercializes over-the-counter and consumer health products across Colombia, Ecuador, and Peru. The company operates through three wholly-owned legal entities (Genfar S.A. and Genfar Desarrollo y Manufactura S.A. in Colombia, Genfar del Perú S.A.C., and Genfar del Ecuador S.A.S.) and is part of the Brazil-based Eurofarma group. Its portfolio spans analgesics (acetaminophen, ibuprofen), antihistamines (cetirizine), topical anti-inflammatories (diclofenac gel), antifungals (clotrimazole), gastrointestinal treatments (diosmectite), and respiratory remedies (Hedera helix), with a dedicated pediatric sub-brand called Genfar Kids offering age-appropriate formulations.

Genfar's commercial model is built on broad retail distribution through more than 35 named pharmacy chains across its three operating markets (including Cruz Verde, Inkafarma, Farmatodo, Boticas Perú, Rappi, and others), complemented by listings on major online pharmacy marketplaces. The company supports three distinct customer segments — general consumers, physicians, and pharmacists — through differentiated channels: a consumer health-education portal (Te Cuidamos), a dedicated pharmacist platform (HiGen), and a physician portal (Medicamentos PLM). Bioequivalence and interchangeability studies on select products are positioned as a quality differentiator under the company's "Calidad Internacional" branding.

Revenue mechanics rely on high-volume, low-ticket OTC unit sales across multiple therapeutic categories rather than enterprise contracts or institutional anchors. Genfar does not disclose pricing publicly, directing consumers to individual pharmacy listings. The company maintains 1,001–5,000 employees, active social media presence (Facebook), and a WhatsApp customer-service channel, but shows no disclosed AI/ML capability, proprietary digital products, APIs, or external funding activity in the available source material.

Name

Genfar

Legal name

Genfar S.A.

Website

https://genfar.com

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Genfar is a Colombian-founded (1967) generic pharmaceutical manufacturer operating in Colombia, Ecuador, and Peru as a subsidiary of the Brazil-based Eurofarma group, selling OTC medications and pediatric formulations through 35+ pharmacy chains and online marketplaces.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Generic pharmaceuticals
• Over-the-counter medications
• Pediatric medications
• Pharmaceutical manufacturing
• Consumer health products

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Generic Pharmaceutical Products (OTC and prescription): Genfar manufactures and commercializes a broad portfolio of generic medications across therapeutic categories including analgesics (acetaminophen, ibuprofen), antihistamines (cetirizine), anti-inflammatories (diclofenac gel), antacids (aluminum acetate), antidiarrheals (diosmectite), and respiratory treatments (Hedera helix). Revenue is generated through direct sales to pharmacies and pharmacy chains across Colombia, Ecuador, and Peru, as well as through online pharmacy marketplace listings.

Go-to-market motion2 records

Distribution channels7 records

Marketing channels6 records

Core offering

Genfar manufactures and commercializes a broad portfolio of generic pharmaceutical products, both over-the-counter and prescription, across therapeutic categories including analgesics (acetaminophen, ibuprofen), antihistamines (cetirizine), anti-inflammatory gels (diclofenac), antifungals (clotrimazole), antidiarrheals (diosmectite), and respiratory treatments (Hedera helix). The company supports select products with bioequivalence and interchangeability studies and distributes through physical pharmacy chains and online pharmacy marketplaces in Colombia, Ecuador, and Peru.

Product overview

Genfar is a pharmaceutical company founded in 1967 in Colombia, offering a portfolio of over-the-counter (OTC) medications and consumer health products. The company's product offerings include analgesics (acetaminophen, ibuprofen), antihistamines (cetirizine), anti-inflammatory topical treatments (diclofenac gel), antifungals (clotrimazole), gastrointestinal treatments (diosmectite), and respiratory remedies (hedera helix). Genfar operates through two main product lines: its general OTC portfolio for adults and the Genfar Kids sub-brand specializing in pediatric formulations. The company also provides health education content through its 'Te Cuidamos' portal. Genfar distributes products across Colombia, Ecuador, and Peru, offering medications both through traditional pharmacy channels and online retailers.

Differentiator

Problem solved

Functional benefit

Brands

• Genfar Kids: A special product line dedicated to children's healthcare, offering pediatric formulations including acetaminophen, ibuprofen, hedera helix, and cetirizine for various child health needs.

Products and services

• Genfar Kids Dedicated product line of pediatric formulations for children's healthcare needs, including Hedera helix (respiratory), acetaminophen, ibuprofen (analgesic/antipyretic), and cetirizine (antihistamine) in child-appropriate dosages. Targets parents and caregivers of children across Colombia, Ecuador, and Peru.
• Acetaminophen (multiple dosage strengths, including pediatric) Over-the-counter analgesic and antipyretic available in adult (500mg) and pediatric (100mg and 160mg) strengths, including a combination formulation with caffeine for enhanced pain relief. Used for mild to moderate pain relief and fever reduction across all age groups.
• Ibuprofen (multiple dosage strengths, including pediatric) Nonsteroidal anti-inflammatory drug (NSAID) available in adult (800mg) and pediatric (100mg) strengths for anti-inflammatory, analgesic, and antipyretic purposes.
• Cetirizine (multiple dosage strengths, including pediatric) Antihistamine medication for relief of allergy symptoms, available in adult (10mg) and pediatric formulations for children.
• Diclofenac Gel Topical NSAID gel for localized pain and inflammation relief. Applied externally to treat site-specific inflammatory and musculoskeletal pain.
• Diosmectite 3g Intestinal adsorbent medication for the treatment of acute diarrhea. Used for symptomatic relief of digestive disturbances.
• Clotrimazole Topical antifungal medication for the treatment of fungal skin infections.
• Aluminum Acetate pH 4.5 Topical astringent solution for skin care and treatment of minor skin irritations.
• Hedera helix Herbal expectorant used for cough relief and respiratory conditions. Available in both adult and pediatric (Genfar Kids) formulations.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Eurofarma: Eurofarma is the Brazilian parent company and a direct peer in the LATAM generic and branded pharmaceutical market. It operates an overlapping portfolio of generics, OTCs, and prescription drugs across Latin America, sharing manufacturing know-how, regulatory practices, and portfolio management with Genfar.
• Chalver: Chalver is a Colombian generics manufacturer producing a broad portfolio of OTC and prescription medications sold through similar pharmacy distribution channels, directly overlapping with Genfar's therapeutic categories and customer base.
• Procaps: Procaps is a Colombian pharmaceutical company with a significant generics and consumer health portfolio, operating across Latin America with similar B2B pharmacy relationships and overlapping OTC product lines that compete head-to-head with Genfar.
• Lafrancol: Lafrancol is a Colombian generic pharmaceutical manufacturer with a broad OTC and prescription portfolio distributed through major pharmacy chains, making it a direct competitor to Genfar in the Colombian market.
• Tecnoquímicas: Tecnoquímicas is one of Colombia's largest pharmaceutical manufacturers, producing a broad generics and OTC portfolio that directly competes with Genfar in the Colombian market across similar therapeutic categories and pharmacy channels.

Broad incumbents

• Teva Pharmaceutical Industries: Teva is one of the world's largest generic pharmaceutical manufacturers with established LATAM operations, offering a broad generic portfolio that competes with Genfar on price and availability in Colombia, Ecuador, and Peru.
• Sandoz (Novartis): Sandoz is the global generic pharmaceutical division of Novartis and a broad incumbent in LATAM generics, offering a far larger product portfolio that competes with Genfar across multiple molecule categories and provides benchmark pricing pressure on regional manufacturers.
• Bayer Consumer Health: Bayer's consumer health division markets leading OTC brands across analgesics, antihistamines, and antifungals in LATAM, overlapping with Genfar's portfolio categories and competing for the same pharmacy shelf space and consumer spend.
• Sanofi Consumer Healthcare: Sanofi is Genfar's former corporate parent and a major multinational pharmaceutical company with a substantial LATAM OTC and generics portfolio, sharing historical institutional knowledge and overlapping product categories in the same three countries.

Regional players

• MKSalud / MK (Colombia): MK is a Colombian consumer health and OTC brand with broad distribution through pharmacy chains and supermarkets in Colombia, competing with Genfar in similar over-the-counter categories targeted at the same value-conscious consumer segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/GenfarSA
• Xx.com/genfarmercadeo
• LinkedInlinkedin.com/company/genfar

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genfar